Unilever has announced its agreement to acquire Grüns, a rapidly expanding U.S. supplement company known for its innovative gummy products. This strategic purchase marks a significant step in Unilever's plan to enhance its Beauty & Wellbeing portfolio. The deal underscores the consumer goods giant's commitment to investing in premium, high-growth brands within the American market.
A Strategic Move for Portfolio Optimization
The acquisition aligns with Unilever's broader corporate strategy of refining its business focus. The company has been actively optimizing its portfolio, which includes the recent demerger of its ice cream division. This move is part of a larger plan to become a leading pure-play home and personal care company with a stronger U.S. presence.
Grüns represents an ideal addition, fitting squarely into Unilever's emphasis on premium segments and digital commerce. Jostein Solheim, Unilever Wellbeing CEO, highlighted the brand's unique combination of efficacy and an enjoyable user experience. Unilever sees a significant opportunity to scale the brand and leverage its innovative, science-backed product line within its existing business.
The Rise of an Innovative Supplement Brand
Founded in 2023 by Chad Janis, Grüns was established to solve a key industry challenge. Janis identified that the biggest barrier to supplement use was not awareness but consistent adherence. The company’s mission was therefore to transform daily nutrient support into an easy and enjoyable ritual for consumers.
The brand quickly became a leader in the U.S. greens supplement category with its popular "superfood" gummies. Each gummy contains over 60 ingredients, including organic fruits, vegetables, and prebiotic fiber. This successful formula has attracted over one million customers through both retail and direct-to-consumer channels across the country.
Demonstrating its commitment to innovation, Grüns has already expanded its product offerings significantly since its launch. The company introduced Grüns Kids for children and Nütrops for cognitive support in 2024. Further expansions in 2025 included Immün for immune system support and Jüced for enhanced energy, showcasing its rapid development.
Future Outlook and Market Context
Looking ahead, the partnership with Unilever is set to accelerate Grüns' growth trajectory significantly. Founder Chad Janis stated the collaboration will enable the company to reach more people and move faster. The acquisition combines Grüns' agile, culture-driven brand identity with Unilever’s extensive resources and global reach for powerful synergy.
This deal also reflects a wider trend within the nutritional supplement market. Consumers are increasingly favoring more convenient and palatable formats like gummies over traditional powders. Grüns' success in this area positions it perfectly to capitalize on this ongoing shift in consumer preferences for accessible wellness products.
In summary, Unilever's acquisition of Grüns is a calculated move to bolster its presence in the lucrative U.S. wellness sector. The partnership provides Grüns with the necessary backing for substantial expansion while aligning with Unilever's strategic portfolio goals. While financial terms were not disclosed, the transaction is expected to be finalized later this year pending regulatory approval.